In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections.

Abstract	Against 443 aerobic and anaerobic bacteria isolated from diabetic foot infections, ceftobiprole MICs (microg/ml) at which 90% of the isolates tested were inhibited were as follows: methicillin-resistant Staphylococcus aureus, 1; methicillin-susceptible S. aureus and Staphylococcus lugdunensis, 0.5; Anaerococcus prevotii, 0.125; Finegoldia magna, 0.5; Peptoniphilus asaccharolyticus, 1; Peptostreptococcus anaerobius, 4; Escherichia coli and Enterobacter species, 0.125; Klebsiella species, 2; and Pseudomonas aeruginosa, 8.
Authors	Ellie J C Goldstein, Diane M Citron, C Vreni Merriam, Yumi A Warren, Kerin L Tyrrell, Helen T Fernandez
Journal	Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 50 Issue 11 Pg. 3959-62 (Nov 2006) ISSN: 0066-4804 [Print] United States
PMID	16982780 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Anti-Bacterial Agents Cephalosporins ceftobiprole
Topics	Anti-Bacterial Agents (pharmacology) Bacteria, Aerobic (drug effects) Bacteria, Anaerobic (drug effects) Cephalosporins (pharmacology) Diabetic Foot (microbiology) Drug Resistance, Bacterial Humans Microbial Sensitivity Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!